15 Conferences, Masterclasses & Events Since 2023

Indus Cancer Conclave 2026

Decoding Oncology's Future: Advances Unveiled

The 2nd Indus Cancer Conclave brings together distinguished oncologists, researchers, and healthcare professionals from across India. Organised under the aegis of OIATI and in association with Indus Hospital Group, the event features keynote addresses, evidence-based panel discussions, and opportunities for peer networking across all major cancer types.

Convenor  Dr. Deepak Singla, Dr. Rajandeep Singh Sethi & Dr. Aprajita Mall, Indus International Hospital, Mohali

Partners  Indus Hospital Group, AMD GlobalNet, Ayushman Cancer Care

Breast, Lung & GI Cancer Update 2026

From Chest to Gut: Navigating Breast, Lung and GI Cancers

A focused 2-day virtual session bringing together leading experts to discuss the latest advancements in Breast, Lung, and Gastrointestinal Cancers. Organised under the aegis of OIATI and supported by Indraprastha Apollo Hospital, the program features insightful lectures and case-based panel discussions.

Convenor  Dr. Ankit Jain, Senior Consultant, Medical Oncology, Indraprastha Apollo Hospital, New Delhi

Partners  Indraprastha Apollo Hospital, AstraZeneca, Roche, Servier

Lung & GI Cancer Update 2026

Driving Change in Lung and Gastrointestinal Cancer Care

A targeted virtual session examining advances in Lung and Gastrointestinal cancer management. We explored predictive modelling of immunotherapy efficacy in driver gene-negative NSCLC and evidence-based strategies for optimising outcomes in colorectal cancer.

Convenor  Dr. Deepak Singla, Medical Oncologist, Indus International Hospital, Mohali

Immuno-Oncology 2026

Advancing Immunotherapy in Oncology Practice

A focused virtual session exploring the latest advancements in immunotherapy across cancer types. We brought together leading oncologists to discuss transforming patient outcomes in TNBC, newer trends in RCC treatment, and immunotherapy applications in esophageal cancer in the Indian clinical context.

Convenor  Dr. Deepak Singla, Medical Oncologist, Indus International Hospital, Mohali

Partners  Dr. Reddy's Laboratories

National Uro Oncology Quiz 2026

Innovation & Equity in Genito-Urinary Malignancies

A prestigious national-level quiz for oncology trainees, bringing together multidisciplinary teams from DM/DNB/MCH institutions across India. We provided travel grants and hospitality to all nominated teams. Cash prizes: ₹75,000 (1st), ₹50,000 (2nd), ₹30,000 (3rd).

Convenor  Research & Education Society of Medical Oncology (RESMO)

Partners  RESMO

2nd AIIMS Uro-Oncology Updates & Best of ESMO 2025

Innovation and Equity in Genito-Urinary Malignancies

A landmark 2-day academic conference on genitourinary malignancies paired with a comprehensive review of the Best of ESMO 2025. Organised by RESMO and supported by OIATI, this conference featured distinguished international faculty from leading cancer centres in the USA, delivering actionable insights for immediate clinical practice.

Partners  MSD, AstraZeneca, Eli Lilly, Bayer, Roche, Pfizer, Novartis, Zydus, Intas, Astellas, Medgenome, Glenmark, Intuitive

Personalised Cancer Therapy in Lung Cancer

A Road to Cancer Cure

A focused evening session bringing together leading experts in lung cancer management. We explored personalised cancer therapy approaches, from screening and diagnosis challenges to surgical oncology's evolving role, and what physicians need to know to drive better patient outcomes.

Convenor  Dr. Nithin S. G., Consultant, Medical Oncology, Fortis Hospital, Vasant Kunj, New Delhi

Partners  AstraZeneca, ZycusLife, VSTIM Health Services

Onco Voyage: Navigating Breakthroughs from Molecule to Bedside

Translational Oncology Webinar

A focused live webinar navigating the latest breakthroughs in lung cancer management, from molecular diagnostics and early-stage EGFR-mutated NSCLC therapy to immunotherapy outcomes in advanced disease. The session also featured evidence-based nutritional management in post-oncologic care.

Convenor  Dr. Sadashivudu G., Professor & HOD, Department of Medical Oncology, NIMS, Hyderabad

Partners  AstraZeneca, Axiom Max, Zycuslife, BioWision

Recent Advancements in Oncology 2025

Advances in Breast Cancer and Palliative Care

A focused evening session bringing together experts to discuss recent advancements in oncology and cancer care. Organised under the aegis of OIATI and supported by BLK-MAX Super Speciality Hospital, the event featured case-based discussions on early breast cancer, SBRT applications, and bridging gaps in palliative care.

Convenor  Dr. Chandragouda Dodagoudar, Senior Director & HOD, Medical Oncology, BLK-Max Super Speciality Hospital, Delhi

Partners  BLK-MAX Super Speciality Hospital

Indus Cancer Conclave 2025

Understanding the Advances in Oncology

Our inaugural Indus Cancer Conclave brought together distinguished oncologists, researchers, and healthcare professionals from across India. Organised under the aegis of OIATI in association with Indus Hospital Group, the event featured keynote addresses, evidence-based panel discussions, and sponsored sessions. Awarded 8 CME credit hours by the Punjab Medical Council.

Convenor  Dr. Deepak Singla & Dr. Rajandeep Singh Sethi, Indus International Hospital, Mohali

Partners  AstraZeneca, Roche, Glenmark, MSD, Dr. Reddy's, J&J, Zydus, Intas, Merck, Fresenius Kabi, Lucien, Halsted, Adley, Reliance Life Sciences, MAPS

OncoShala-3

3rd Annual International Oncology Conference

A comprehensive 2-day international oncology conference bringing together clinicians, researchers, students, and healthcare professionals. Organised under SPARSSH and supported by OIATI, the event featured an Eli Lilly International Speaker Program with Dr. Marc Thill (Germany) and covered breakthrough advancements across all major cancer types.

Convenor  Dr. Sushant Mittal, Director, Medical Oncology & Hematology, Action Cancer Hospital, New Delhi

Partners  AstraZeneca, Roche, J&J, MSD, Merck, Takeda, Novartis, Lilly, Eris, Glenmark, Pfizer, Servier, Sun Pharma, Alkem, Zydus, Fresenius Kabi, Torrent, Dr. Reddy's, Lupin, BDR, Hetero Healthcare

OncoShala-2

2nd Annual Oncology Seminar

A landmark 2-day seminar bringing together leading oncologists across India. Organised under SPARSSH, the event ran parallel sessions across two halls, featuring case-based discussions, ISP sessions, and an International Speaker Program on frontline mRCC. Topics spanned breast, lung, GI, GU, gynae, and hematology cancers.

Convenor  Dr. Sushant Mittal, Director, Medical Oncology & Hematology, Action Cancer Hospital, New Delhi

Partners  AstraZeneca, Novartis, Eisai, J&J, Dr. Reddy's, Intas, MSD, Roche, Cellgen, Sun Pharma, Samarth, BD, Eris, Natco, LifeCell, Hetero, Emcure, Lilly, Axiom, Lucien, Merck, Cipla, Alkem, RPG Life Sciences, 4baseCare, Wembrace, Fresenius Kabi, Celon Pharma

OncoShala 2023: 2nd Seminar

2nd Oncology Conference of 2023

The second oncology seminar of 2023, bringing together national experts across all major cancer streams. A dedicated ISP session featured Dr. Tudor-Eliade Ciuleanu (Romania) on dual checkpoint inhibitors in frontline mNSCLC. The event spanned six cancer sessions across 2 days with case-based discussions and sponsored symposia.

Convenor  Dr. Sushant Mittal, Associate Director, Medical Oncology, Max Hospital, Shalimar Bagh, New Delhi

Partners  AstraZeneca, Roche, Novartis, BMS, MSD, Lilly, Takeda

OncoShala-1: Filling the Gap in Oncology

1st Annual Oncology Seminar

The inaugural OncoShala seminar, bringing together experts from across India to discuss the latest research, treatment options, and advancements in cancer care. Organised under SPARSSH, the event featured keynote lectures, panel discussions, and an ISP session with Dr. Amit Singal on HCC. Five cancer streams were covered across 2 days.

Convenor  Dr. Samit Purohit, Associate Director, Medical Oncology, Max Hospital, Shalimar Bagh, New Delhi

Partners  BMS, MSD, AstraZeneca, Roche, Novartis, Lilly, Takeda, Merck, Onecelldx

Academic Workshop in Upper GI Tract Carcinoma

Biliary Tract Cancers & Hepatocellular Carcinoma

A full-day academic workshop focused on the future of GI cancer care, covering immunotherapy, genetics, molecular markers, and newer techniques. The event ran four structured sessions covering biliary tract cancers (epidemiology, imaging, surgery, molecular biology) and hepatocellular carcinoma (immunotherapy and targeted therapy).

Convenor  Dr. Sushant Mittal, Associate Director, Medical Oncology, Max Hospital, Shalimar Bagh, New Delhi

Partners  MAX Healthcare, AstraZeneca, Roche, Shilpa